Latest round

Series B

Last raised

Aug 2024

Total raised

$242M

Investors

9

About IDRX

IDRX, Inc.IDRX, Inc. is dedicated to developing groundbreaking therapies for gastrointestinal cancer. Founded in 2022 in Plymouth, US, the company has successfully completed 3 deals. The firm was co-founded by Alexis Borisy and Ben Auspitz, who has a background in founding other notable companies.IDRX, Inc. focuses on creating cutting-edge pharmaceutical products aimed at treating gastrointestinal cancers. Their innovative solutions target significant health challenges and are designed to improve patient outcomes.The revenue for IDRX stems from its product offerings in the pharmaceutical sector, primarily through sales to healthcare providers and partnerships with distributors.In January 2025, GlaxoSmithKline Plc fully acquired IDRX, Inc. for USD 1 billion, with an additional USD 150 million allocated for milestone payments. This acquisition will enhance GSK's gastrointestinal cancer portfolio, supporting the launch of new therapeutic solutions.

Who invested in IDRX

9 investors across 2 rounds

See all investors in IDRX

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Aug 7, 2024

    Amount

    $120M

    Investors

    Locked

  2. Series A

    May 10, 2022

    Amount

    $122M

    Investors

    Locked

Questions about IDRX

Who invested in IDRX?

IDRX has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has IDRX raised?

IDRX has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did IDRX last raise money?

IDRX's most recent round on record is a Series B, in Aug 2024.

What does IDRX do?

IDRX is a biotechnology company.

Where is IDRX headquartered?

IDRX is headquartered in Plymouth, US.

Which VCs invest in companies like IDRX?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at IDRX's stage. Their profiles are linked below.

Raising like IDRX? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.